We are live on ! Find out more
PAMU

Pictet Asset Management (UK) Portfolio holdings

AUM $91.8B
1-Year Est. Return 47.77%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+47.77%
3 Year Est. Return
+102.96%
5 Year Est. Return
+189.45%
10 Year Est. Return
AUM
$91.8B
AUM Growth
+$8.58B
Cap. Flow
+$2.33B
Cap. Flow %
2.53%
Top 10 Hldgs %
12.39%
Holding
1,892
New
100
Increased
613
Reduced
867
Closed
139

Sector Composition

Rank Sector Weight
1 Technology 28.89%
2 Healthcare 15.52%
3 Industrials 13.05%
4 Consumer Discretionary 9.92%
5 Utilities 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETN icon
451
Eaton
ETN
$157B
$28.1M 0.03%
189,954
-14,749
-7% -$2.13M
AUPH icon
452
Aurinia Pharmaceuticals
AUPH
$1.97B
$28.1M 0.03%
2,170,394
-1,636,862
-43% -$20.9M
JAZZ icon
453
Jazz Pharmaceuticals
JAZZ
$15.9B
$28M 0.03%
157,657
-73,920
-32% -$12.8M
ARE icon
454
Alexandria Real Estate Equities
ARE
$8.88B
$27.9M 0.03%
153,397
+72,027
+89% +$12.9M
LHCG
455
DELISTED
LHC Group LLC
LHCG
$27.8M 0.03%
138,733
+17,414
+14% +$3.49M
HIG icon
456
Hartford Financial Services
HIG
$38.5B
$27.7M 0.03%
447,064
-44,108
-9% -$2.89M
GWW icon
457
W.W. Grainger
GWW
$65.3B
$27.5M 0.03%
62,834
+3,937
+7% +$1.74M
DCPH
458
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$27.5M 0.03%
751,098
+11,617
+2% +$450K
ARGX icon
459
argenx
ARGX
$57.4B
$27.1M 0.03%
89,564
-3,474
-4% -$988K
HCA icon
460
HCA Healthcare
HCA
$84.8B
$26.8M 0.03%
129,448
-664
-0.5% -$135K
EXPD icon
461
Expeditors International
EXPD
$22.9B
$26.6M 0.03%
210,355
-9,964
-5% -$1.18M
VST icon
462
Vistra
VST
$55.1B
$26.6M 0.03%
1,431,809
-7,102
-0.5% -$123K
AFMD
463
DELISTED
Affimed
AFMD
$26.6M 0.03%
312,375
+211,445
+209% +$19.3M
FCX icon
464
Freeport-McMoran
FCX
$90B
$26.5M 0.03%
715,334
+93,901
+15% +$3.66M
ITB icon
465
PUT
iShares US Home Construction ETF
ITB
$2.41B
$26.5M 0.03%
382,200
DQ
466
Daqo New Energy
DQ
$790M
$26.4M 0.03%
406,579
+120,650
+42% +$8.67M
BMO icon
467
Bank of Montreal
BMO
$125B
$26.3M 0.03%
256,558
-15,327
-6% -$1.51M
SRPT icon
468
Sarepta Therapeutics
SRPT
$1.66B
$26.2M 0.03%
336,845
+54,760
+19% +$4.15M
DRE
469
DELISTED
Duke Realty Corp.
DRE
$26.1M 0.03%
552,046
+121,338
+28% +$5.6M
PACB icon
470
Pacific Biosciences
PACB
$422M
$26M 0.03%
744,897
+47,379
+7% +$1.38M
AFYA icon
471
Afya
AFYA
$1.27B
$26M 0.03%
1,007,817
+86,792
+9% +$2.04M
BN icon
472
Brookfield
BN
$102B
$25.8M 0.03%
938,493
+56,935
+6% +$1.46M
BX icon
473
Blackstone
BX
$104B
$25.8M 0.03%
265,883
+2,630
+1% +$234K
ACAD icon
474
Acadia Pharmaceuticals
ACAD
$4.25B
$25.7M 0.03%
1,055,164
-27,660
-3% -$624K
COLM icon
475
Columbia Sportswear
COLM
$3.19B
$25.7M 0.03%
261,349
+7,941
+3% +$833K

Similar funds

Pictet Asset Management (UK)'s Q2 2021 Portfolio in Review

As of Q2 2021, Pictet Asset Management (UK) held 1,892 positions worth $91.8B, up 10% from $83.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Pictet Asset Management (UK)'s Q2 2021 filing shows 100 new, 613 increased, 867 reduced and 139 closed positions. Its largest new stake was Oatly Group: 140,026 shares worth $68.5M. The largest sale was Alibaba, an estimated $550M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Pictet Asset Management (UK)'s largest Q2 2021 buy was Oatly Group: 140,026 shares worth $68.5M.
  • Pictet Asset Management (UK) added most to Equinix in Q2 2021, an estimated $221M increase.
  • Pictet Asset Management (UK)'s biggest Q2 2021 reduction was Alibaba, cutting an estimated $550M.
  • Pictet Asset Management (UK) fully exited ChemoCentryx, Inc. in Q2 2021, selling an estimated $62.6M.
  • Pictet Asset Management (UK)'s ten largest holdings make up 12% of its $91.8B portfolio in Q2 2021.
  • Pictet Asset Management (UK) opened 100 new positions and closed 139 in Q2 2021.
  • Pictet Asset Management (UK)'s portfolio value rose 10% quarter-over-quarter to $91.8B.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.